dirlotapide (Slentrol)

Indications

• used to treat obesity in dogs

Contraindications

• not intended for use in humans, cats, or parrots

Dosage

• oral solution

Mechanism of action

• microsomal triglyceride transfer protein (MTTP) inhibitor
• inhibits assembly & release of lipoproteins
• reduces fat absorption
• elicits a satiety signal from lipid-filled cells lining the intestine

More general terms

• metabolic agent (metabolic modifier)
• enzyme inhibitor